Overall rank by patents
#42,709
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: E06B (FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES).
The verdict
Rollease holds 6 US patents across 1 technology areas, rank #42,709 of 50,000 tracked assignees.
Rollease Acmeda, Inc. has been granted 6 US utility patents between 2021 and 2025, placing Rollease Acmeda, Inc. at rank #42,709 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.3 claims per patent with primary concentration in E06B (FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES). As a US Corporation, Rollease Acmeda, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Rollease sits between Rodin Therapeutics, Inc. (6 patents, rank #42,705) and Roof Asset Management USA, Ltd. (6 patents, rank #42,713) - the closest US assignees by grant volume. The composite Innovation Score of 33.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Rollease Acmeda, Inc.'s 5.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Rollease Acmeda, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Rodin Therapeutics, Inc.
6 patents
Rofin-Sinar Laser GmbH
6 patents
Rohm Powervation Limited
6 patents
Rokko Systems Pte Ltd
6 patents
Rolling Optics AB
6 patents
Roly LLC
6 patents
Ronan Tools Inc.
6 patents
Roof Asset Management USA, Ltd.
6 patents
Rollease Acmeda, Inc.
6 patents
What this shows Rollease holds 6 patents at rank #42,709, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,709 in granted patent volume.
Other assignees with the most granted patents in Rollease's primary technology class.
Rollease's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 55% higher than 45% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 16.7% |
| 2024 | 4 | 66.7% |
| 2025 | 1 | 16.7% |
Top 1 of 1 technology areas
Overall rank by patents
#42,709
Across all tracked assignees
33.5 out of 100
How to use this portfolio
Rollease's 6 grants land it in the top 55% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.